Literature DB >> 26338863

Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.

E M Streicher1, S L Sampson1, K Dheda2, T Dolby3, J A Simpson3, T C Victor1, N C Gey van Pittius1, P D van Helden1, R M Warren4.   

Abstract

We show that the interpretation of molecular epidemiological data for extensively drug-resistant tuberculosis (XDR-TB) is dependent on the number of different markers used to define transmission. Using spoligotyping, IS6110 DNA fingerprinting, and DNA sequence data, we show that XDR-TB in South Africa (2006 to 2008) was predominantly driven by the acquisition of second-line drug resistance.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26338863      PMCID： PMC4609696          DOI： 10.1128/JCM.01414-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis.

Authors:  G D van der Spuy; R M Warren; M Richardson; N Beyers; M A Behr; P D van Helden
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.

Authors:  Thomas R Frieden; Sonal S Munsiff; Shama Desai Ahuja
Journal:  Int J Tuberc Lung Dis       Date:  2007-01       Impact factor: 2.373

3.  Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence.

Authors:  O J Strauss; R M Warren; A Jordaan; E M Streicher; M Hanekom; A A Falmer; H Albert; A Trollip; E Hoosain; P D van Helden; T C Victor
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

Review 4.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

5.  Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.

Authors:  Elize Pietersen; Elisa Ignatius; Elizabeth M Streicher; Barbara Mastrapa; Xavier Padanilam; Anil Pooran; Motasim Badri; Maia Lesosky; Paul van Helden; Frederick A Sirgel; Robin Warren; Keertan Dheda
Journal:  Lancet       Date:  2014-01-17       Impact factor: 79.321

Review 6.  Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements.

Authors:  D Van Soolingen
Journal:  J Intern Med       Date:  2001-01       Impact factor: 8.989

7.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

8.  The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa.

Authors:  Thomas R Ioerger; Yicheng Feng; Xiaohua Chen; Karen M Dobos; Thomas C Victor; Elizabeth M Streicher; Robin M Warren; Nicolaas C Gey van Pittius; Paul D Van Helden; James C Sacchettini
Journal:  BMC Genomics       Date:  2010-11-26       Impact factor: 3.969

9.  Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.

Authors:  Borna Müller; Violet N Chihota; Manormoney Pillay; Marisa Klopper; Elizabeth M Streicher; Gerrit Coetzee; Andre Trollip; Cindy Hayes; Marlein E Bosman; Nicolaas C Gey van Pittius; Thomas C Victor; Sebastien Gagneux; Paul D van Helden; Robin M Warren
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

10.  Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.

Authors:  Marisa Klopper; Robin Mark Warren; Cindy Hayes; Nicolaas Claudius Gey van Pittius; Elizabeth Maria Streicher; Borna Müller; Frederick Adriaan Sirgel; Mamisa Chabula-Nxiweni; Ebrahim Hoosain; Gerrit Coetzee; Paul David van Helden; Thomas Calldo Victor; André Phillip Trollip
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883
View more
  5 in total

1.  Role of MIRU-VNTR and spoligotyping in assessing the genetic diversity of Mycobacterium tuberculosis in Henan Province, China.

Authors:  Jie Shi; Danwei Zheng; Yankun Zhu; Xiaoguang Ma; Shaohua Wang; Hui Li; Jin Xing
Journal:  BMC Infect Dis       Date:  2018-09-03       Impact factor: 3.090

2.  Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review.

Authors:  Namaunga Kasumu Chisompola; Elizabeth Maria Streicher; Chishala Miriam Kapambwe Muchemwa; Robin Mark Warren; Samantha Leigh Sampson
Journal:  BMC Infect Dis       Date:  2020-05-13       Impact factor: 3.090

3.  Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.

Authors:  Camus Nimmo; James Millard; Lucy van Dorp; Kayleen Brien; Sashen Moodley; Allison Wolf; Alison D Grant; Nesri Padayatchi; Alexander S Pym; François Balloux; Max O'Donnell
Journal:  Lancet Microbe       Date:  2020-08

4.  Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.

Authors:  Crystal A Shanley; Marcela I Henao-Tamayo; Chand Bipin; Raja Mugasimangalam; Deepshika Verma; Diane J Ordway; Elizabeth M Streicher; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2018-02-09       Impact factor: 3.131

5.  Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis.

Authors:  Kirsten E Wiens; Lauren P Woyczynski; Jorge R Ledesma; Jennifer M Ross; Roberto Zenteno-Cuevas; Amador Goodridge; Irfan Ullah; Barun Mathema; Joel Fleury Djoba Siawaya; Molly H Biehl; Sarah E Ray; Natalia V Bhattacharjee; Nathaniel J Henry; Robert C Reiner; Hmwe H Kyu; Christopher J L Murray; Simon I Hay
Journal:  BMC Med       Date:  2018-10-30       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.